Tranexamic Acid for the Latarjet Procedure.

• Status: Completed
• Trial end date: 2019-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure.

The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sports Surgery Clinic, Santry, Dublin
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Anterior shoulder instability, warranting the Latarjet procedure

Exclusion Criteria:

• Patients with known risk factors for hyper-coagulable state

• Patients under 16

• Patients unable to give consent to partake in the trial